Idenix's (IDIX) Renaud Says Will Take 18-24 Months to Resolve Patent Case with Gilead (GILD) -Reuters

Article Stock Quotes (2) Comments (0)

Traders should watch Idenix Pharma (Nasdaq: IDIX) shares as Reuters is reporting the company's CEO Ron Renaud has said he believes it will take about 18-24 months in order to resolve the patent cases with Gilead (Nasdaq: GILD).

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hess (HES), Elliott to End Proxy Contest; Three Elliott Nominees Will be Added
• Accretion to Actavis (ACT) from Warner Chilcott (WCRX) Deal Could Be Substantial - Jefferies
• UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF

Create E-mail Alert Related Categories

Litigation, Rumors

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?